Greek hospitals begin administering “monoclonic antibodies” to Covid patients

On Thursday, the Ministry of Health announced that hospitals in Greece will begin injecting monoclonal antibodies to patients with Covid-19, primarily those at high risk of infection belonging to vulnerable groups.

Recently, the country received 2000 doses of monoclonic antibodies. According to Deputy Minister of Health Mina Gaga, the use of the drug will take place in hospitals with the greatest experience of doctors. Priority patients are reported to be:

with a weakened immune system; those who have received a transplant; patients with neoplasm; pregnant in the last three months.

Patients must be 12 years of age or older and have tested positive for coronavirus using a PCR test within the past 5 days. Monoclonal antibodies are used as a single dose, but this requires a hospital, since they are administered intravenously and require hours of medical supervision for possible allergic reactions.

The American biotech company announced on Monday that a single dose of Regen-COV treatment will prevent 81.6% of infections for at least eight months. This means that synthetic antibodies can provide long-term protection for immunocompromised patients who do not respond to vaccinations. Therapies are prescribed by doctors who also initiate the application process. Monoclonic antibody therapy will be provided at the following ten public hospitals:

Athens: Sotiria, Sismanoglu. Thessaloniki: AHEPA, Papageorgiou. General hospitals in Alexandroupoli, Heraklion, Ioannina, Larisa, Lamia, Patras / Rio. Sources: amna,

Source link

High-quality journalistic work cannot be free, otherwise it becomes dependent on the authorities or the oligarchs.
Our site is solely funded by advertising money.
Please disable your ad blocker to continue reading the news.
Best regards, editors